Jia Longfei, Ye Jing, L V Haiyan, Wang Weishan, Zhou Chunkui, Zhang Xiaojun, Xu Jiangtao, Wang Lingling, Jia Jianping
Department of Neurology, Xuan Wu Hospital of the Capital Medical University, Beijing, PR China.
Brain Res. 2007 Apr 13;1141:10-4. doi: 10.1016/j.brainres.2007.01.005. Epub 2007 Jan 8.
Presenilin enhancer 2 (Pen2) is a subunit of the gamma-secretase complex which cleaves amyloid precursor protein (APP) to generate amyloid beta (Abeta). We performed a systematic screening of all Pen2 exons and introns using direct sequencing to assess its role in the risk of developing late onset Alzheimer's disease (LOAD). 947 subjects (LOAD: 467;
早老素增强子2(Pen2)是γ-分泌酶复合物的一个亚基,该复合物切割淀粉样前体蛋白(APP)以产生β淀粉样蛋白(Aβ)。我们使用直接测序法对所有Pen2外显子和内含子进行了系统筛查,以评估其在晚发性阿尔茨海默病(LOAD)发病风险中的作用。本研究招募了947名受试者(LOAD组:467名;对照组:480名)。我们发现了三个多态性位点:rs10402601、rs3817622和rs2293688。在这三个多态性位点中,rs3817622与载脂蛋白E(APOE)基因型之间存在相互作用(P=0.002)。在携带APOE 4等位基因的受试者中,LOAD组和对照组之间的等位基因分布(P=0.003)和基因型分布(P=0.007)存在显著差异。以等位基因T和基因型T/T为参照,等位基因A以及T/A+A/A基因型的比值比[95%置信区间(CI)]分别为4.720(1.517 - 10.654)和3.886(1.381 - 10.932)。我们的结果表明,在中国北方人群中,rs3817622与APOE ε4携带者患LOAD之间存在关联。Pen2基因的等位基因A可能会增加患LOAD的风险。